TKNO יחס מהיר Alpha Teknova, Inc.

Alpha Teknova, Inc. (TKNO) is betting on the supply of key buffers and reagents for gene therapy, creating an adaptive synthesis system tailored to client needs. The business is implementing robotics in nutrient media filling shops to guarantee sterility and reduce personnel costs. Plant capacities are currently fully utilized, as confirmed by the 3.62 metric. This chart on the page demonstrates the asset's current price action.

Steady demand for Alpha Teknova, Inc. (TKNO) reagents is reflected in the dynamics of the quick ratio. This indicator determines the company's ability to instantaneously settle short-term liabilities without liquidating inventory. The calculation is based exclusively on liquid assets—cash and accounts receivable. High business margins allow the company to maintain this level, guaranteeing capital stability even amidst a sharp rise in operating expenses.